Home › BIO expresses concerns with Medical Innovation Act.
 

Keywords :   


BIO expresses concerns with Medical Innovation Act.

2015-02-06 14:30:57| Industrial Newsroom - All News for Today

Introduced by Senator Elizabeth Warren (D-MA), Medical Innovation Act proposes to increase funding for the National Institutes of Health by creating a new statutory scheme that would impose fee on biopharmaceutical companies working on critical treatments and cures for patients. According to BIO President and CEO, Jim Greenwood, BIO supports increased funding for NIH, but has serious concerns about the impact this legislation would have on research and development.

Tags: medical act concerns bio

Category:Industrial Goods and Services

Latest from this category

All news
01.10Boosting Membership Value
Industrial Goods and Services »
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »